ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,563, issued on Oct. 27, was assigned to Medtronic Inc. (Minneapolis).

"Two stage risk assessment for predicting imminent acute cardiac episodes" was invented by Xiaohong Zhou (Woodbury, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A medical device system determines first values associated with a first plurality of patient parameters associated with arrhythmic substrate and/or physiological triggers for acute cardiac events based on a first one or more of the physiological signals generated during the period and determines, based on the first values associated with the first plurality of patient parameters, whether to assess alterations in ca...